for patients

Cooperations

Process development:
Geneart AG, D-93053 Regensburg

Quality management:
CMC Pharma, D-68161 Mannheim

Preclinical studies:
Oncotest GmbH, D-79108 Freiburg
In vitro, Prof. Dr. G. Unteregger, D-66424 Homburg/Saar
NOTOX, NL-5203 DL’s-Hertogenbosch
hameln rds a.s. (formerly VULM), SK-90001 Modra

Clinical studies:
Study site: Principal Investigator: Professor Michael Pfreundschuh, MD Department of Internal Medicine I, Saarland University Hospital, D-66421 Homburg/Saar
CRO: AAI Pharma GmbH & Co. KG, D-89231 Neu-Ulm

Strategic partnership
In March 2004 SymbioTec GmbH has signed a privileged partnership with Eurogentec S.A., Seraing, Belgium, the contract manufacturer of ONCOHIST for the development of novel histone-based cancer therapeutics.